Title: Clinical observation of Tongxinluo capsule combined with low-molecular-weight haparin calcium in treating unstable angina pectoris
Abstract: Objective:To investigate the therapeutic effect of Tongxinluo capsule combined with low-molecular-weight haparin calcium on unstable angina pectoris. Methods:38 patients with unstable angina pectoris were randomly divided into two groups. 22 patients in treatment group were treated by 0.4ml low-molecular-weight haparin calcium, once per 12 hours, for a treatment course of 7 days, and Tongxinluo capsule four pills once, three times a day, for a treatment course of 7 days. 16 patients in control group only were given antiunstable angina pectoris routine medicines for 7 days. The hemorhedogy changes and clinical effect and ECG changes were observed before and after treatment. Results:The hemorhedogy changes including whole blood viscosity, hematocrit, fibriogen and ECG and clinical effect were improved after treatment, and the changes of whole blood viscosity, fibriogen, hematocrit in treatment group were superior to those of control group ( P0.01, P0.01, P0.05 ). The clinical effect and ECG of the total effective rate in treatment group were 95.5% and 90.5%, respectively, and 68.7% and 62.5% in control group, respectively. There was a significant difference between two groups (P0.01). Conclusion:Tongxinluo capsule combined with low-molecular-weight haparin calcium is effective and safe in treating unstable angina pectoris.
Publication Year: 2005
Publication Date: 2005-01-01
Language: en
Type: article
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot